Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France. [electronic resource]
- Chest 04 2020
- 945-954 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1931-3543
10.1016/j.chest.2019.10.045 doi
Age Factors Aged Correlation of Data Drug Therapy, Combination--methods Endothelin Receptor Antagonists--therapeutic use Female France--epidemiology Humans Hypertension, Pulmonary--diagnosis Male Middle Aged Phosphodiesterase 5 Inhibitors--therapeutic use Retrospective Studies Risk Assessment--methods Scleroderma, Systemic--complications Survival Analysis